Literature DB >> 3917317

Impaired antipneumococcal antibody production in patients without spleens.

F Di Padova, M Dürig, F Harder, C Di Padova, C Zanussi.   

Abstract

Fifteen splenectomised and 15 normal subjects were studied, in absence of any intentional immunisation, for pokeweed mitogen induced synthesis of antipneumococcal capsular polysaccharide antibodies in vitro by peripheral blood mononuclear cells. Results showed that removal of the spleen had caused a persistent immune deficiency of circulating B cells capable of synthesising IgM antipneumococcal capsular polysaccharide. In vitro synthesis of polyclonal IgM and IgG by peripheral blood mononuclear cells of subjects without spleens was also depressed. These defects were due to an abnormality of the B cell compartment. These data are evidence of the major role of the spleen in the control and production of a consistent part of pokeweed mitogen responsive circulating B cells and add another facet to the complex immune dysfunction of splenectomised subjects. The findings, moreover, may help in understanding the susceptibility of splenectomised people to pneumococcal sepsis and the delayed and impaired antibody response to pneumococcal vaccine.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3917317      PMCID: PMC1415385          DOI: 10.1136/bmj.290.6461.14

Source DB:  PubMed          Journal:  Br Med J (Clin Res Ed)        ISSN: 0267-0623


  14 in total

1.  Effects of splenectomy on the humoral immune system. A study in neonatally and adult splenectomized mice.

Authors:  J Rozing; N H Brons; R Bennner
Journal:  Immunology       Date:  1978-05       Impact factor: 7.397

2.  Suppressor T cell activity in splenectomized subjects.

Authors:  I Melamed; V Zakuth; E Tzechoval; Z Spirer
Journal:  J Clin Lab Immunol       Date:  1982-04

3.  Alterations in immunoglobulin synthesis by peripheral blood mononuclear cells from splenectomized patients with and without splenic regrowth.

Authors:  P A Drew; G K Kiroff; A Ferrante; R C Cohen
Journal:  J Immunol       Date:  1984-01       Impact factor: 5.422

4.  Splenic role in the regulation of immune responses.

Authors:  C G Romball; W O Weigle
Journal:  Cell Immunol       Date:  1977-12       Impact factor: 4.868

5.  Marginal zones: the major B cell compartment of rat spleens.

Authors:  D S Kumararatne; H Bazin; I C MacLennan
Journal:  Eur J Immunol       Date:  1981-11       Impact factor: 5.532

6.  Antibody responses to meningococcal polysaccharide vaccine in adults without a spleen.

Authors:  F L Ruben; W A Hankins; Z Zeigler; C W Norden; A Harrison; A Winkelstein; D J Herrmann
Journal:  Am J Med       Date:  1984-01       Impact factor: 4.965

7.  Peripheral blood mononuclear cells of splenectomized patients are unable to differentiate into immunoglobulin-secreting cells after pokeweed mitogen stimulation.

Authors:  C Müller; J W Mannhalter; R Ahmad; G Zlabinger; P Wurnig; M M Eibl
Journal:  Clin Immunol Immunopathol       Date:  1984-04

8.  Specific anti-influenza virus antibody production in vitro by lymphocytes from a subset of patients with hypogammaglobulinemia.

Authors:  R Yarchoan; H S Schneider; B B Wray; D L Nelson
Journal:  J Clin Invest       Date:  1983-06       Impact factor: 14.808

9.  Splenectomy and subsequent mortality in veterans of the 1939-45 war.

Authors:  C D Robinette; J F Fraumeni
Journal:  Lancet       Date:  1977-07-16       Impact factor: 79.321

10.  Immune response after splenectomy.

Authors:  J L Sullivan; H D Ochs; G Schiffman; M R Hammerschlag; J Miser; E Vichinsky; R J Wedgwood
Journal:  Lancet       Date:  1978-01-28       Impact factor: 79.321

View more
  11 in total

1.  Impaired proliferative responses of peripheral blood B cells from splenectomized subjects to phorbol ester and ionophore.

Authors:  P N Foster; L K Trejdosiewicz
Journal:  Clin Exp Immunol       Date:  1992-09       Impact factor: 4.330

2.  The spleen? Who needs it anyway?

Authors:  M Hazlewood; D S Kumararatne
Journal:  Clin Exp Immunol       Date:  1992-09       Impact factor: 4.330

3.  Intradermal hepatitis B vaccine in thalassaemia and sickle cell disease.

Authors:  Q Mok; G Underhill; B Wonke; M Aldouri; M Kelsey; D Jefferies
Journal:  Arch Dis Child       Date:  1989-04       Impact factor: 3.791

4.  Pneumococcal septic arthritis after splenectomy in Felty's syndrome.

Authors:  M Brzeski; L Smart; D Baird; R Jackson; R Sturrock
Journal:  Ann Rheum Dis       Date:  1991-10       Impact factor: 19.103

Review 5.  Immunogenicity and immunochemistry of Streptococcus pneumoniae capsular polysaccharides.

Authors:  J E van Dam; A Fleer; H Snippe
Journal:  Antonie Van Leeuwenhoek       Date:  1990-06       Impact factor: 2.271

6.  Infections in splenectomised patients: guidelines for management.

Authors:  J W van der Meer
Journal:  Clin Investig       Date:  1993-01

7.  Splenic autotransplantation and the immune system. Adequate testing required for evaluation of effect.

Authors:  W Timens; R Leemans
Journal:  Ann Surg       Date:  1992-03       Impact factor: 12.969

8.  Neutrophil chemotaxis in sickle cell anaemia, sickle cell beta zero thalassaemia, and after splenectomy.

Authors:  E A Donadi; R P Falcão
Journal:  J Clin Pathol       Date:  1987-06       Impact factor: 3.411

9.  The C-type lectin SIGN-R1 mediates uptake of the capsular polysaccharide of Streptococcus pneumoniae in the marginal zone of mouse spleen.

Authors:  Young-Sun Kang; Jae Y Kim; Sandra A Bruening; Maggi Pack; Anna Charalambous; Alla Pritsker; Thomas M Moran; Jutta M Loeffler; Ralph M Steinman; Chae Gyu Park
Journal:  Proc Natl Acad Sci U S A       Date:  2003-12-23       Impact factor: 11.205

10.  "How safe is splenectomy?".

Authors:  S T O'Sullivan; C M Reardon; J A O'Donnell; W O Kirwan; M P Brady
Journal:  Ir J Med Sci       Date:  1994-08       Impact factor: 1.568

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.